ILLUMINA, INC.

By person

52 insiders · 915 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Meister Keith A.

Director

—

$591.13M (93)

−$591.13M

1,811,040

1.20%

$396.94M

−62.8%

FLATLEY JAY T

Director

—

$139.11M (126)

−$139.11M

152,433

0.1009%

$33.41M

−62.4%

Ronaghi Mostafa

SVP, Entrepreneurial Devlopmt

—

$45.40M (81) scheduled

−$45.40M

80,162

0.0531%

$17.57M

+37.2%

deSouza Francis A

President and CEO

—

$26.33M (149)

−$26.33M

120,992

0.0801%

$26.52M

+100.2%

OSTADAN OMEAD

SVP Mktg, Prod & Strat Plan

—

$8.97M (31)

−$8.97M

17,172

0.0114%

$3.76M

−17.4%

Van Oene Mark

SVP Chief Commercial Officer

—

$8.31M (38) scheduled

−$8.31M

16,575

0.0110%

$3.63M

−14.7%

TOUSI SUSAN H

SVP, Chief Commercial Officer

—

$7.72M (47)

−$7.72M

89,267

0.0591%

$19.57M

+3.5%

Dadswell Charles

SVP, General Counsel

—

$7.54M (55)

−$7.54M

26,790

0.0177%

$5.87M

+116.4%

Aravanis Alexander

SVP, Chief Technology Officer

—

$6.52M (24)

−$6.52M

12,587

0.0083%

$2.76M

+7,261%

EPSTEIN ROBERT S

Director

—

$6.00M (20) scheduled

−$6.00M

22,139

0.0147%

$4.85M

+167.5%

RAGUSA ROBERT P

SVP, Global Quality & Ops

—

$5.91M (24)

−$5.91M

9,617

0.0064%

$2.11M

−12.3%

Stapley Marc

EVP Strategy & Corp Developmt

—

$5.90M (62)

−$5.90M

6,957

0.0046%

$1.52M

−63.9%

BOWMAN A BLAINE

Director

—

$5.20M (35) scheduled

−$5.20M

15,946

0.0106%

$3.50M

+1.5%

EASTHAM KARIN

Director

—

$4.30M (21) scheduled

−$4.30M

10,049

0.0067%

$2.20M

−15.7%

Hoyt Aimee L

SVP, Chief People Officer

—

$4.21M (25)

−$4.21M

8,314

0.0055%

$1.82M

+953.7%

Bouchard Michel

Chief Accounting Officer

—

$2.85M (9)

−$2.85M

9,538

0.0063%

$2.09M

−55.1%

SAMAD SAM

SVP and CFO

—

$2.32M (7)

−$2.32M

11,297

0.0075%

$2.48M

—

Thaysen Jacob

Chief Executive Officer

$1.99M (10)

—

+$1.99M

109,073

0.0722%

$23.91M

+14,521%

Febbo Phillip G.

SVP Chief Medical Officer

—

$1.72M (8)

−$1.72M

14,786

0.0098%

$3.24M

+747.8%

ARNOLD FRANCES

Director

—

$1.20M (5)

−$1.20M

20,907

0.0138%

$4.58M

+125.7%

MCGINNIS KAREN K

VP, Chief Accounting Officer

—

$1.18M (5)

−$1.18M

1,538

0.0010%

$337.10K

+308.0%

BRADBURY DANIEL

Director

—

$751.13K (13) scheduled

−$751.13K

15,324

0.0101%

$3.36M

−6.9%

Davies Scott M

Chief Legal Officer

—

$531.27K (5) scheduled

−$531.27K

20,338

0.0135%

$4.46M

+46.5%

Leckman Patricia

SVP, Chief People Officer

—

$529.72K (9) scheduled

−$529.72K

21,259

0.0141%

$4.66M

+127.1%

Dhingra Ankur

SVP, Chief Financial Officer

$495.38K (1)

—

+$495.38K

34,264

0.0227%

$7.51M

+19,258%

DORSA CAROLINE

Director

—

$450.00K (1)

−$450.00K

15,754

0.0104%

$3.45M

+29,625%

Wedel Christensen Jakob

SVP, Strategy/Corp Development

—

$366.14K (3) scheduled

−$366.14K

14,023

0.0093%

$3.07M

+300.9%

Ericksen Scott D

VP, Chief Accounting Officer

—

$305.15K (2) scheduled

−$305.15K

14,446

0.0096%

$3.17M

+113.5%

Gottlieb Scott

Director

$84.63K (2)

—

+$84.63K

14,795

0.0098%

$3.24M

+27,815%

ORPIN TRISTAN

EVP Clinical Genomics

—

118,259

0.0783%

$25.92M

−0.6%

Cunningham Everett

SVP, Chief Commercial Officer

—

41,942

0.0278%

$9.19M

+18,377%

Barnard Steven

SVP, Chief Technology Officer

—

40,927

0.0271%

$8.97M

+104.7%

Pegels Kevin Carl

Chief of Global Operations

—

29,038

0.0192%

$6.36M

+415.9%

GOSWAMI JOYDEEP

SVP, Chief Financial Officer

—

24,478

0.0162%

$5.37M

+6,681%

SCHILLER PHILIP W

Director

—

22,220

0.0147%

$4.87M

+830.5%

Coletti Julie Ann

Chief Legal Officer

—

18,763

0.0124%

$4.11M

—

Rollins Carissa

SVP, Chief Information Officer

—

18,447

0.0122%

$4.04M

+2,040%

Reeves Kathryne Gambrell

SVP, Chief Marketing Officer

—

17,965

0.0119%

$3.94M

—

HENRY CHRISTIAN O

EVP & Chief Commercial Officer

—

17,531

0.0116%

$3.84M

−7.6%

SIEGEL SUSAN E

Director

—

16,535

0.0110%

$3.62M

+31,098%

GUTHART GARY S

Director

—

16,430

0.0109%

$3.60M

+23,041%

Ullem Scott B.

Director

—

11,030

0.0073%

$2.42M

+20,711%

THOMPSON JOHN WENDELL

Director

—

10,162

0.0067%

$2.23M

+19,074%

Frank John Edward

Chief Public Affairs Officer

—

9,166

0.0061%

$2.01M

—

RICHO ANNA

Director

—

8,527

0.0056%

$1.87M

+15,989%

Hampton Malcolm Garret

SVP Clinical Genomics Group

—

6,598

0.0044%

$1.45M

+86.8%

Sullivan Michael C

Chief Commercial Officer

—

4,503

0.0030%

$986.97K

—

MACMILLAN STEPHEN P

Director

—

4,129

0.0027%

$904.99K

—

KING DAVID P

Director

—

2,072

0.0014%

$454.14K

—

TORRES JOSE

VP, Chief Accounting Officer

—

1,748

0.0012%

$383.13K

+3,078%

Skovronsky Daniel

Director

—

1,674

0.0011%

$366.91K

—

Teno Andrew

Director

—

1,532

0.0010%

$335.78K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Gottlieb Scott

9 Feb 2026

Director

Buy

200

$117.81

$23.56K

Gottlieb Scott

3 Nov 2025

Director

Buy

500

$122.13

$61.07K

Thaysen Jacob

13 May 2025

Chief Executive Officer

Buy

100

$82.26

$8.23K

Thaysen Jacob

13 May 2025

Chief Executive Officer

Buy

804

$81.56

$65.57K

Thaysen Jacob

13 May 2025

Chief Executive Officer

Buy

4,946

$80.70

$399.14K

Thaysen Jacob

12 May 2025

Chief Executive Officer

Buy

200

$82.66

$16.53K

Thaysen Jacob

12 May 2025

Chief Executive Officer

Buy

1,400

$81.54

$114.16K

Thaysen Jacob

12 May 2025

Chief Executive Officer

Buy

3,700

$80.92

$299.40K

Thaysen Jacob

12 May 2025

Chief Executive Officer

Buy

1,200

$79.70

$95.64K

Dhingra Ankur

12 May 2025

SVP, Chief Financial Officer

Buy

6,100

$81.21

$495.38K

Thaysen Jacob

22 Feb 2024

Chief Executive Officer

Buy

692

$137.18

$94.93K

Thaysen Jacob

22 Feb 2024

Chief Executive Officer

Buy

1,553

$135.69

$210.73K

Thaysen Jacob

22 Feb 2024

Chief Executive Officer

Buy

5,085

$134.91

$686.02K

Showing 250 of 915 transactions. The figures above use every one of them.

By person

Individual transactions

What was left out